# Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

> **NCT03452111** · PHASE2 · COMPLETED · sponsor: **Premier Research** · enrollment: 420 (actual)

## Conditions studied

- Healthy
- Men
- Male Contraception

## Interventions

- **DRUG:** Nestorone + Testosterone Combination Gel

## Key facts

- **NCT ID:** NCT03452111
- **Lead sponsor:** Premier Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-25
- **Primary completion:** 2024-09-06
- **Final completion:** 2024-09-06
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2025-02-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452111, "Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03452111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*